[Predictors of thromboembolic complications in patients with severe SARS-CoV-2 coronavirus infection].

Valery I Podzolkov E V Volchkova Aida I Tarzimanova Anna E Bragina Alexander Ivannikov Ekaterina E Sokolova Ilya Shvedov Karine Oganesyan Alyona Isaeva

Published in: Terapevticheskii arkhiv (2023)

The presence of severe comorbid pathology significantly increased the risk of developing a feasibility study in patients with COVID-19. The most significant predictors of the development of feasibility studies in patients with severe SARS-CoV-2 coronavirus infection. They are: CHD, arterial hypertension and type 2 diabetes.

Keyphrases

sars cov
respiratory syndrome coronavirus
type diabetes
arterial hypertension
early onset
cardiovascular disease
drug induced
atrial fibrillation
glycemic control
metabolic syndrome
coronavirus disease
case control